Mark Ragosa Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

Mark Ragosa is CHIEF FINANCIAL OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 23,382 shares of KNSA, which is worth approximately $532,174. The most recent transaction as insider was on Mar 20, 2025, when has been sold 15,944 shares (Class A Ordinary Share) at a price of $23.11 per share, resulting in proceeds of $368,465. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.4K

1.85% 3M change

49.58% 12M change

Total Value Held $532,174

Mark Ragosa Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Date	Transaction	Value	Shares Traded	Shares Held	Form
Mar 20 2025	SELL Open market or private sale	$368,465 $23.11 p/Share	15,944 Reduced 40.54%	23,382 Class A Ordinary Share
Mar 20 2025	BUY Exercise of conversion of derivative security	$206,793 $12.97 p/Share	15,944 Added 28.85%	39,326 Class A Ordinary Share
Mar 19 2025	SELL Open market or private sale	$205,104 $23.1 p/Share	8,879 Reduced 27.52%	23,382 Class A Ordinary Share
Mar 19 2025	BUY Exercise of conversion of derivative security	$115,160 $12.97 p/Share	8,879 Added 21.58%	32,261 Class A Ordinary Share
Mar 17 2025	SELL Open market or private sale	$264,818 $23.1 p/Share	11,464 Reduced 32.9%	23,382 Class A Ordinary Share
Mar 17 2025	BUY Exercise of conversion of derivative security	$148,688 $12.97 p/Share	11,464 Added 24.75%	34,846 Class A Ordinary Share
Mar 16 2025	SELL Payment of exercise price or tax liability	$10,129 $22.61 p/Share	448 Reduced 1.88%	23,382 Class A Ordinary Share
Mar 16 2025	BUY Exercise of conversion of derivative security	-	872 Added 3.53%	23,830 Class A Ordinary Share
Mar 12 2025	SELL Open market or private sale	$809,277 $22.25 p/Share	36,372 Reduced 61.3%	22,958 Class A Ordinary Share
Mar 12 2025	BUY Exercise of conversion of derivative security	$435,372 $11.97 p/Share	36,372 Added 38.01%	59,330 Class A Ordinary Share
Dec 09 2024	SELL Open market or private sale	$403,226 $21.38 p/Share	18,860 Reduced 45.1%	22,958 Class A Ordinary Share
Dec 09 2024	BUY Exercise of conversion of derivative security	$209,346 $11.1 p/Share	18,860 Added 31.08%	41,818 Class A Ordinary Share
Dec 06 2024	SELL Open market or private sale	$190,770 $21.27 p/Share	8,969 Reduced 28.09%	22,958 Class A Ordinary Share
Dec 06 2024	BUY Exercise of conversion of derivative security	$25,888 $10.76 p/Share	2,406 Added 8.66%	25,364 Class A Ordinary Share
Dec 05 2024	SELL Open market or private sale	$23,863 $21.25 p/Share	1,123 Reduced 4.66%	22,958 Class A Ordinary Share
Dec 05 2024	BUY Exercise of conversion of derivative security	$12,083 $10.76 p/Share	1,123 Added 4.46%	24,081 Class A Ordinary Share
Dec 04 2024	SELL Open market or private sale	$106,760 $21.25 p/Share	5,024 Reduced 17.95%	22,958 Class A Ordinary Share
Dec 04 2024	BUY Exercise of conversion of derivative security	$54,058 $10.76 p/Share	5,024 Added 15.22%	27,982 Class A Ordinary Share
Dec 03 2024	SELL Open market or private sale	$192,385 $21.45 p/Share	8,969 Reduced 28.09%	22,958 Class A Ordinary Share
Dec 03 2024	BUY Exercise of conversion of derivative security	$96,506 $10.76 p/Share	8,969 Added 21.93%	31,927 Class A Ordinary Share
Sep 02 2024	SELL Payment of exercise price or tax liability	$25,563 $26.74 p/Share	956 Reduced 4.0%	22,958 Class A Ordinary Share
Sep 02 2024	BUY Exercise of conversion of derivative security	-	1,861 Added 7.22%	23,914 Class A Ordinary Share
Sep 01 2024	SELL Payment of exercise price or tax liability	$60,432 $26.74 p/Share	2,260 Reduced 9.3%	22,053 Class A Ordinary Share
Sep 01 2024	BUY Exercise of conversion of derivative security	-	4,444 Added 15.45%	24,313 Class A Ordinary Share
Jul 23 2024	SELL Open market or private sale	$601,107 $24.79 p/Share	24,248 Reduced 55.74%	19,253 Class A Ordinary Share

Mark Ragosa

CHIEF FINANCIAL OFFICER

Hamilton, D0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Value

Any

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA

Account